Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL28209290 | 0.98 | TSHR (0.37) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL10889597 | 0.84 | TSHR (0.37) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL8968296 | 0.84 | TSHR (0.37) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL524563 | 0.79 | TSHR (0.38) | TSHRALDH1A1 | |
| SCHEMBL11322949 | 0.78 | HCAR2 (0.38) | — | |
| SCHEMBL11322959 | 0.78 | HCAR2 (0.38) | — | |
| SCHEMBL2549996 | 0.78 | — | — | |
| SCHEMBL17138350 | 0.77 | TSHR (0.39) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL3226362 | 0.77 | ALDH1A1 (0.43) | TSHRALDH1A1LMNAMAPTTDP1 | |
| SCHEMBL5308320 | 0.77 | FAAH (0.44) | LMNAMAPTTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108059639-B | Industrial synthesis method of acetoxypropyl trimethoxy silane | 荆州市江汉精细化工有限公司 | 2020-05-19 | — | — | CN | claimed |
| CN-108059639-A | A kind of industrial preparative method of acetyloxypropyl trimethoxy silane | 荆州市江汉精细化工有限公司 | 2018-05-22 | — | — | CN | claimed |
| EP-2580294-B1 | PVDF COATING COMPOSITIONS | SOLVAY SOLEXIS SPA (IT) | 2015-02-25 | — | — | EP | claimed |
| EP-2580294-A1 | PVDF COATING COMPOSITIONS | Solvay Solexis S.p.A. (IT) | 2013-04-17 | — | — | EP | claimed |
| US-20130090417-A1 | PVDF coating compositions | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2013-04-11 | — | — | US | claimed |
| WO-2011157657-A1 | PVDF COATING COMPOSITIONS | SOLVAY SOLEXIS S.P.A. (IT) | 2011-12-22 | — | — | WO | claimed |
| EP-3687652-B1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | WATERS TECHNOLOGIES CORP (US) | 2025-07-09 | — | — | EP | disclosed |
| US-20230256413-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | WATERS TECHNOLOGIES CORPORATION (US) | 2023-08-17 | — | — | US | disclosed |
| EP-4129466-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | Waters Technologies Corporation (US) | 2023-02-08 | — | — | EP | disclosed |
| CN-111405934-B | Method for isolating, separating, purifying or detecting acidic polar molecules | 沃特世科技公司 | 2022-04-26 | — | — | CN | disclosed |
| US-20210220753-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2021-07-22 | — | — | US | disclosed |
| US-10974167-B2 | High purity chromatographic materials comprising an ionizable modifier | WATERS TECHNOLOGIES CORPORATION (US) | 2021-04-13 | — | — | US | disclosed |
| CN-112206822-A | Composite carrier catalyst for preparing acetoxy propyl alkoxy silane and preparation method thereof | 安徽硅宝有机硅新材料有限公司 | 2021-01-12 | — | — | CN | disclosed |
| US-20090143606-A1 | Production process for a silicon compound | JNC CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090137765-A1 | Polymer obtained by addition-polymerization initiated by a silicon compound | JNC CORPORATION (JP) | 2009-05-28 | — | — | US | disclosed |
| US-20070004932-A1 | Silicon compound and a production process for silicon compound | JNC CORPORATION (JP) | 2007-01-04 | — | — | US | disclosed |
| US-20060287454-A1 | Silicon compounds | JNC CORPORATION (JP) | 2006-12-21 | — | — | US | disclosed |
| US-7129370-B2 | Silicon compound and a production process for silicon compound | CHISSO CORPORATION (JP) | 2006-10-31 | — | — | US | disclosed |
| US-20050033077-A1 | Production process for silicon compound and the same | JNC CORPORATION (JP) | 2005-02-10 | — | — | US | disclosed |
| US-4329483-A | FROM A CHLOROSILANE AND ACYLOXY COMPOUND; BY-PRODUCT INHIBITION | DOW CORNING CORPORATION (US) | 1982-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143606-A1 | Production process for a silicon compound | NAF1, H1-0, SPTBN1 | TSHR 2393/4885CHRM2 2290/4885CHRM4 2417/4885 |
| US-20070004932-A1 | Silicon compound and a production process for silicon compound | STS, SMS, SRM | TSHR 1330/4885CHRM2 550/4885CHRM4 1724/4885 |
| US-20060287454-A1 | Silicon compounds | H1-0, SPTBN1, SPTAN1 | TSHR 2568/4885CHRM2 2255/4885CHRM4 2658/4885 |
| US-20050033077-A1 | Production process for silicon compound and the same | STS, SMS, SFXN1 | TSHR 1571/4885CHRM2 403/4885CHRM4 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.